26 January 2020
Strategy and digital communication for the TATAMI biomedical research project
In January 2019, the Translational Genomics Research Group, led by Dr. Rubén Artero and part of the INCLIVA Health Research Institute and the University of Valencia (Spain), contacted us to ask us to put together a digital communication strategy, within the framework of the TATAMI project. This project, which was awarded a Health Research grant in 2018 from “la Caixa”, aims to design the first effective drug for Myotonic Dystrophy Type 1, a serious neurodegenerative disease for which there is currently no cure or treatment.
The project leaders wanted to share their research with the scientific community and especially with patients affected by the disease and their families. We started work: analysing the websites and social media where the project would be shared, and proposing how we would prepare the different materials, in English and Spanish, as well as drafting a content plan schedule for 2019.
More specifically, we designed and produced an explanatory video that placed special emphasis on the origins of the research conducted by Dr. Artero, a world leader in the study of the molecular mechanisms of the disease. We also produced a trailer for the video, several multimedia clips with specific content for experts, and an infographic explaining the main characteristics of the therapeutic approach taken in the project. All this was accompanied by written texts adapted for news websites and social media platforms (Facebook, Twitter and Instagram).
We are excited to have formed part of this project, which is a model of pioneering research carried out here in Spain, in collaboration with other top-level centres in Europe. And we hope that the drug will soon be available to those who need it.
